Abstract

IntroductionGlucocorticoid induced down-regulation of systemic inflammation in ARDS is associated with a significant improvement in pulmonary and extrapulmonary organ dysfunction and a reduction in duration of mechanical ventilation and ICU length of stay [1].We aimed in this study to evaluate the effect of methyl prednisolone when used early in ARDS. Patients and methodsWe studied 27 patients with ARDS, we divided them randomly into two groups the first group consists of 18 patients received methyl prednisolone and the other group consists of 9 patients did not receive it. All patients were subjected daily to: history taking and clinical examination, Chest X-ray, routine blood investigation (CBC–LFT–RFT–electrolytes), ABG, Serum lactate, INR, fibrinogen, and aptt, CRP, protein C, protein S, and D-dimer at the beginning and at the end of study. ResultsAfter 7days there were significant improvements of clinical parameters (pulse, temperature, and systolic blood pressure), peep (one parameter from lung injury score), lactate, D-dimer, AST, and a highly significant improvement of creatinine in the methyl prednisolone group when compared to the control group. After 14days from starting treatment there were significant improvements of clinical parameters (pulse and systolic BP), ventilator parameters (FIO2, peep, and RR), systemic inflammation markers organ functions (O2sat, lactate, creatinine, WBCs, AST, and GGT) and CRP. And a significant improvement of CX-ray, earlier extubation from mechanical ventilation and improvement of mortality in the methyl prednisolone group when compared with the control group. ConclusionWe conclude that methyl prednisolone when used on first 2days in ARDS patients improves the LIS, decreases the systemic inflammation, earlier extubation from mechanical ventilation, and decreases the incidence of hospital acquired infection.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.